Alkem Laboratories Ltd 2019 AR2
The report highlights a landmark year for Alkem Laboratories Limited as its revenues crossed the USD 1 billion milestone, driven by strong brand building, manufacturing, and R&D investments. The company's domestic business maintained its leading position in acute therapies while expanding rapidly in chronic segments. Internationally, the US business delivered robust growth of 38.9% year-on-year, supported by a healthy pipeline of ANDA filings. Alkem also continued its commitment to sustainable development through community health, education, and rural development initiatives.
Company: Alkem Laboratories Ltd
Sector: Manufacturing
Country: India
Year: 2019
Type: AR2
Pages: 245
Back to company
Alkem Laboratories Ltd
Annual Report
The report highlights a landmark year for Alkem Laboratories Limited as its revenues crossed the USD 1 billion milestone, driven by strong brand building, manufacturing, and R&D investments. The company's domestic business maintained its leading position in acute therapies while expanding rapidly in chronic segments. Internationally, the US business delivered robust growth of 38.9% year-on-year, supported by a healthy pipeline of ANDA filings. Alkem also continued its commitment to sustainable development through community health, education, and rural development initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees